- Home
- BTO vs ORIC Comparison
BTO vs ORIC Comparison
Compare BTO & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTO
- ORIC
- Stock Information
- Founded
- BTO 1994
- ORIC 2014
- Country
- BTO United States
- ORIC United States
- Employees
- BTO N/A
- ORIC N/A
- Industry
- BTO Investment Managers
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- BTO Finance
- ORIC Health Care
- Exchange
- BTO Nasdaq
- ORIC Nasdaq
- Market Cap
- BTO N/A
- ORIC 545.5M
- IPO Year
- BTO N/A
- ORIC 2020
- Fundamental
- Price
- BTO $33.15
- ORIC $7.70
- Analyst Decision
- BTO
- ORIC Strong Buy
- Analyst Count
- BTO 0
- ORIC 9
- Target Price
- BTO N/A
- ORIC $18.43
- AVG Volume (30 Days)
- BTO 54.2K
- ORIC 981.7K
- Earning Date
- BTO 01-01-0001
- ORIC 05-05-2025
- Dividend Yield
- BTO 9.13%
- ORIC N/A
- EPS Growth
- BTO N/A
- ORIC N/A
- EPS
- BTO N/A
- ORIC N/A
- Revenue
- BTO N/A
- ORIC N/A
- Revenue This Year
- BTO N/A
- ORIC N/A
- Revenue Next Year
- BTO N/A
- ORIC N/A
- P/E Ratio
- BTO N/A
- ORIC N/A
- Revenue Growth
- BTO N/A
- ORIC N/A
- 52 Week Low
- BTO $22.95
- ORIC $6.33
- 52 Week High
- BTO $32.81
- ORIC $15.40
- Technical
- Relative Strength Index (RSI)
- BTO 30.84
- ORIC 41.92
- Support Level
- BTO $32.00
- ORIC $7.22
- Resistance Level
- BTO $33.34
- ORIC $8.11
- Average True Range (ATR)
- BTO 1.05
- ORIC 0.58
- MACD
- BTO -0.25
- ORIC 0.04
- Stochastic Oscillator
- BTO 29.64
- ORIC 20.78
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.